Hims & Hers Health (HIMS) Cash from Operations Growth (1y) (2020 - 2026)
Hims & Hers Health (HIMS) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 425.00% |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -18.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.09% |
| Dec 31, 2025 | -29.02% |
| Sep 30, 2025 | 74.42% |
| Jun 30, 2025 | -135.67% |
| Mar 31, 2025 | 322.21% |
| Dec 31, 2024 | 292.96% |
| Sep 30, 2024 | 238.48% |
| Jun 30, 2024 | 218.52% |
| Mar 31, 2024 | 172.47% |
| Dec 31, 2023 | 427.18% |
| Sep 30, 2023 | 320.90% |
| Jun 30, 2023 | 363.15% |
| Mar 31, 2023 | 148.87% |
| Dec 31, 2022 | -116.39% |
| Sep 30, 2022 | 137.50% |
| Jun 30, 2022 | -1,163.89% |
| Mar 31, 2022 | -21.66% |
| Dec 31, 2021 | -1,054.28% |
| Sep 30, 2021 | -608.93% |
| Jun 30, 2021 | 487.74% |